Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
NEO

NEOGENOMICS (NEO) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $16.35 +2.1% on the day +82.3% over 12 months 52-week range $7.19 – $19.91

Share price and insider trades

NEO closeInsider buyInsider sale
5101520NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $49,180 on 2025-10-16 · Alicia C OlivoSold $58,908 on 2026-06-15 · Lynn A. TetraultSold $59,916 on 2026-06-09 · Lynn A. TetraultSold $250,992 on 2025-11-25 · Alicia C OlivoSold $276,600 on 2026-01-20 · Warren StoneSold $321,400 on 2026-08-04 · Greg D Aunan
Bought, 12 months$0
Sold, 12 months$1.0M
Insiders buying0
Insiders selling4

NEOGENOMICS insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $1.0M of NEO stock on the open market.

NEO insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $300K sold (2 trades)Q4 2025Q1 2026: $277K sold (1 trades)Q1 2026Q2 2026: $119K sold (2 trades)Q2 2026Q3 2026: $321K sold (1 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$321K1
Q2 2026—0$119K2
Q1 2026—0$277K1
Q4 2025—0$300K2

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.4×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 NEOGENOMICS INC insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $1.0M. 5 of 6 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 6SEC Greg D AunanChief Accounting Officer Sell 20,0005,153 held (−80%) $16.07 $321K +1.7% —
Jun 17SEC Lynn A. TetraultDirector Sell Plan 5,30786,115 held (−6%) $11.10 $59K +47.3% —
Jun 11SEC Lynn A. TetraultDirector Sell Plan 5,30791,422 held (−5%) $11.29 $60K +44.8% —
Jan 21SEC Warren StoneCOO Sell Plan 22,128121,631 held (−15%) $12.50 $277K +30.8% —
Nov 28SEC Alicia C OlivoEvp, Gc & Business Development Sell Plan 20,91631,083 held (−40%) $12.00 $251K +36.3% —
Oct 20SEC Alicia C OlivoEvp, Gc & Business Development Sell Plan 4,91843,022 held (−10%) $10.00 $49K +63.5% —

Insiders at NEOGENOMICS INC

InsiderBoughtSoldLast filingScore
Greg D AunanChief Accounting Officer — $321K Aug 6, 2026 —
Alicia C OlivoEvp, Gc & Business Development — $300K Nov 28, 2025 —
Warren StoneCOO — $277K Jan 21, 2026 —
Lynn A. TetraultDirector — $119K Jun 17, 2026 —

NEO stock: common questions

Are NEOGENOMICS INC insiders buying NEO stock?

In the past 12 months, 0 insiders reported open-market purchases of NEO worth $0.

Are NEOGENOMICS INC insiders selling NEO stock?

4 insiders reported sales worth $1.0M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is NEO's 52-week range?

Over the past year NEO has traded between $7.19 and $19.91. It last closed at $16.35 on Oct 9, 2026.